Factive and Emesis - a phase IV clinical study of FDA data

Summary:

Emesis is reported as a side effect among people who take Factive (gemifloxacin mesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ketek, and have Respiratory tract infection bacterial.

The phase IV clinical study analyzes which people have Emesis when taking Factive. It is created by eHealthMe based on reports of 1,420 people who have side effects when taking Factive from the FDA, and is updated regularly.

What is Factive?

Factive has active ingredients of gemifloxacin mesylate. eHealthMe is studying from 1,430 Factive users. Check the latest studies of Factive.

What is Emesis?

Emesis (process of vomiting) is found to be associated with 4,477 drugs and 5,756 conditions by eHealthMe. Check the latest studies of Emesis.

On Jun, 19, 2026

1,420 people reported to have side effects when taking Factive.
Among them, 27 people (1.9%) have Emesis.

Among these 27 people:

How long have people been on Factive when they have Emesis? *

What is the gender of people who have Emesis when taking Factive? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Emesis when taking Factive? *

What are other drugs people take besides Factive? *

What are other side effects people have besides Emesis? *

Nausea (feeling of having an urge to vomit): 17 people, 62.96%
Dyspnea (difficult or laboured breathing): 7 people, 25.93%
Diarrhea: 7 people, 25.93%
Abdominal Pain Upper: 5 people, 18.52%
Rashes (redness): 4 people, 14.81%
Hypersensitivity: 4 people, 14.81%
Dizziness: 4 people, 14.81%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 3 people, 11.11%
Insomnia (sleeplessness): 3 people, 11.11%
Weakness: 3 people, 11.11%

What are the existing conditions these people have? *

Respiratory Tract Infection Bacterial: 16 people, 59.26%
Sinusitis (inflammation of sinus): 4 people, 14.81%
Respiratory Tract Infection: 3 people, 11.11%
Type 2 Diabetes: 1 person, 3.70%
Quit Smoking: 1 person, 3.70%
Otitis (ear infection): 1 person, 3.70%
Fever: 1 person, 3.70%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 3.70%
Cellulitis (infection under the skin): 1 person, 3.70%
Bronchitis Acute (acute inflammation of the mucous membrane in the bronchial tubes): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Factive and have Emesis?

- Check whether Emesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Factive:

Factive (1,430 reports)

Emesis treatments and more:

Emesis (529,395 reports)

Browse all side effects of Factive:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Emesis:

Emesis (4,477 drugs)

Browse all the conditions that are associated with Emesis:

Emesis (5,756 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemifloxacin mesylate (the active ingredients of Factive) and Factive (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.